Skip to main content
Get Alerts

PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20203
20213
20251
Download CSV

FDA Recall Terminated Historical recordClass III

Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
Superpotent; sodium benzoate preservative
Published
February 12, 2025
Distribution
OH

View recall →

FDA Recall Terminated Historical recordClass II

Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Published
August 18, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cimetidine Hydrochloride Oral Solution 300 mg/5 mL, 8 fl oz (237 mL) Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0649-08

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Published
August 18, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl oz (473 mL) NDC 0121-0868-16; b) 2 fl oz (60 mL) NDC 0121-0868-02; Manufactured by: Pharmaceutical Associates, Inc. Greenville, SC 29605

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Published
August 18, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
Published
October 14, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0810-16

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
Subpotent drug: Out of specification for assay at the 15-month test interval.
Published
August 19, 2020
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.

by PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Reason
SubPotent Drug: Low out-of-specification results for assay testing.
Published
April 1, 2020
Distribution
Nationwide

View recall →

Showing 1–7 of 7 results

This page lists recalls that name PAI Holdings, LLC. dba Pharmaceutical Associates Inc as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.